Basic Information
495
37
10
4.5(31)
Subcategory & Sub-subcategory
Trade Type
Sell
Product Name
Cobenfy
Details
Substance
Manufacturer(s)
Specifications
- IUPAC Name: 3-hexoxy-4-(1-methyl-3,6-dihydro-2H-pyridin-5-yl)-1,2,5-thiadiazole
- EC Number: 683-413-4
- Molecular Weight: 281.42
- Chemical Formula: C14H23N3OS
- CAS Number: 131986-45-3
Other Information
Additional Description:
Cobenfy (formerly KarXT) is described as the first and only FDA-approved schizophrenia therapeutic that avoids direct dopamine D2 receptor binding, combining xanomeline tartrate and trospium chloride as its core active ingredients; it was originally developed by Karuna Therapeutics (now part of Bristol Myers Squibb) and received FDA approval on September 26, 2024. VuRoyal (SuQian) Pharmaceutical Company LLC supplies (rather than manufactures) the product, without samples, distributing it across North America, Central/South America, Western Europe, and Eastern Europe.
Ratings
(0)
(0)
(0)
(0)
(0)
Comments
Filters:
Sort by:
No comments available.
Matched Products & Services
B2B matches based on trade type, category, specifications & price range
Similar Products & Services
Products & Services related to what you're viewing
People Also Viewed
Other products & services viewed by people who looked at this product
Leave your rating & comment